Renin-Angiotensin System Inhibitors in Patients With COVID-19: A Meta-Analysis of Randomized Controlled Trials Led by the International Society of Hypertension.

Sensitivity analyses demonstrated that there were no effects on all‐cause mortality across subgroups based on age, sex, or ethnicity (Figures S8 through S10 ), although there was a nonsignificant trend to increased mortality among the White population with RASi therapy (RR, 1.52; [95% CI, 0.85–2.72]; P =0.16).

also in 5,406 other papers